Clinical Trial Update: Add-on Clioquinol in Drug-resistant Childhood Epilepsy: an Exploratory Study [Phase 2]

View source ↗

Summary

An exploratory Phase 2 trial investigating add-on clioquinol in drug-resistant childhood epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy Intractable

Drugs mentioned

• Clioquinol (clioquinol)

Snippet

Sponsor: KU Leuven | Conditions: Epilepsy Intractable | Phase 2 | Status: UNKNOWN